Key result
Intravenous alteplase was ineffective for treating a cerebral embolism associated with a left atrial myxoma in a 79-year-old man, whose NIHSS score worsened from 24 to 25.
Case Report (n=1)
No
Intravenous thrombolysis may be ineffective for acute ischemic stroke caused by embolization of a cardiac myxoma, suggesting mechanical embolectomy should be considered.
May signal thrombolysis failure in myxoma embolus; hypothesis-generating for mechanical thrombectomy preference.
We present a case of cerebral embolism associated with a left atrial myxoma that was treated with intravenous thrombolytic therapy. A 79-year-old right-handed man with no history of neurological or psychiatric illnesses was referred to our hospital because of confusion. He had been self-supported in the activity of daily living and could enjoy gardening until just before his admission. He had aphasia, left conjugate deviation, right hemiparesis, and right pathological reflexes. His NIHSS score was 24. Cranial DWI showed hyperintense lesions in the left middle cerebral artery territory, and MRA revealed left middle cerebral artery occlusion. We started treatment with the recombinant tissue plasminogen activator alteplase intravenously 3 h after the onset. However, the therapy was ineffective, and the NIHSS score was 25 on the second day. A transthoracic echocardiogram and heart MRI showed a left atrial myxoma. However, surgery was contraindicated because of the patient's poor general condition. Although intravenous recombinant tissue plasminogen activator is a reasonable treatment for stroke patients, even with a cardiac myxoma, we cannot always expect good effects, especially if the emboli are parts of the tumor itself. In this case, we could not perform an endovascular mechanical embolectomy; however, we speculate that mechanical embolus retrieval in cerebral ischemia might be effective in such cases.
No takes yet. Share an insight, caveat, or question.
Kohno et al. (2012) conducted a case report in Cerebral embolism associated with left atrial myxoma (n=1). Intravenous recombinant tissue plasminogen activator (alteplase) was evaluated. Intravenous alteplase was ineffective for treating a cerebral embolism associated with a left atrial myxoma in a 79-year-old man, whose NIHSS score worsened from 24 to 25.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: